1. Home
  2. LEDS vs SYBX Comparison

LEDS vs SYBX Comparison

Compare LEDS & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.96

Market Cap

15.5M

Sector

Technology

ML Signal

HOLD

Logo Synlogic Inc.

SYBX

Synlogic Inc.

N/A

Current Price

$1.10

Market Cap

15.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEDS
SYBX
Founded
2005
N/A
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
15.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
LEDS
SYBX
Price
$1.96
$1.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
68.3K
Earning Date
01-09-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.21
$0.90
52 Week High
$3.37
$1.96

Technical Indicators

Market Signals
Indicator
LEDS
SYBX
Relative Strength Index (RSI) 37.45 26.78
Support Level $1.80 $1.01
Resistance Level $2.00 $1.20
Average True Range (ATR) 0.17 0.09
MACD -0.01 -0.03
Stochastic Oscillator 13.93 13.89

Price Performance

Historical Comparison
LEDS
SYBX

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: